Oil & Gas Exploration & Production
Compare Stocks
4 / 10Stock Comparison
GFR vs SU vs XOM vs CVE
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Integrated
Oil & Gas Integrated
Oil & Gas Integrated
GFR vs SU vs XOM vs CVE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Oil & Gas Exploration & Production | Oil & Gas Integrated | Oil & Gas Integrated | Oil & Gas Integrated |
| Market Cap | $410M | $75.67B | $620.85B | $53.60B |
| Revenue (TTM) | $563M | $52.01B | $323.90B | $49.40B |
| Net Income (TTM) | $-101M | $6.33B | $28.84B | $4.64B |
| Gross Margin | 22.7% | 55.5% | 21.7% | 19.6% |
| Operating Margin | 10.7% | 27.4% | 10.5% | 14.0% |
| Forward P/E | 16.6x | 7.7x | 14.8x | 7.5x |
| Total Debt | $6M | $18.37B | $43.54B | $17.00B |
| Cash & Equiv. | $42M | $3.65B | $10.68B | $2.74B |
GFR vs SU vs XOM vs CVE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 23 | May 26 | Return |
|---|---|---|---|
| Greenfire Resources… (GFR) | 100 | 114.3 | +14.3% |
| Suncor Energy Inc. (SU) | 100 | 185.4 | +85.4% |
| Exxon Mobil Corpora… (XOM) | 100 | 124.6 | +24.6% |
| Cenovus Energy Inc. (CVE) | 100 | 136.7 | +36.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GFR vs SU vs XOM vs CVE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GFR is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 0.05, Low D/E 0.5%, current ratio 1.56x
- Beta 0.05, current ratio 1.56x
- Beta 0.05 vs CVE's 0.22, lower leverage
SU is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth -3.5%, EPS growth 2.8%, 3Y rev CAGR -5.7%
- 197.4% 10Y total return vs CVE's 118.2%
- -3.5% revenue growth vs GFR's -27.4%
- 12.2% margin vs GFR's -17.9%
XOM is the clearest fit if your priority is income & stability.
- Dividend streak 26 yrs, beta -0.15, yield 2.7%
- 2.7% yield, 26-year raise streak, vs CVE's 2.0%, (1 stock pays no dividend)
CVE carries the broadest edge in this set and is the clearest fit for value and momentum.
- Lower P/E (7.5x vs 14.8x)
- +147.0% vs GFR's +43.7%
- 7.8% ROA vs GFR's -7.8%, ROIC 7.9% vs 3.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -3.5% revenue growth vs GFR's -27.4% | |
| Value | Lower P/E (7.5x vs 14.8x) | |
| Quality / Margins | 12.2% margin vs GFR's -17.9% | |
| Stability / Safety | Beta 0.05 vs CVE's 0.22, lower leverage | |
| Dividends | 2.7% yield, 26-year raise streak, vs CVE's 2.0%, (1 stock pays no dividend) | |
| Momentum (1Y) | +147.0% vs GFR's +43.7% | |
| Efficiency (ROA) | 7.8% ROA vs GFR's -7.8%, ROIC 7.9% vs 3.9% |
GFR vs SU vs XOM vs CVE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
GFR vs SU vs XOM vs CVE — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SU leads in 1 of 6 categories
GFR leads 1 • XOM leads 1 • CVE leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
SU leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XOM is the larger business by revenue, generating $323.9B annually — 575.1x GFR's $563M. SU is the more profitable business, keeping 12.2% of every revenue dollar as net income compared to GFR's -17.9%. On growth, SU holds the edge at +25.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $563M | $52.0B | $323.9B | $49.4B |
| EBITDAEarnings before interest/tax | $144M | $21.7B | $59.9B | $12.4B |
| Net IncomeAfter-tax profit | -$101M | $6.3B | $28.8B | $4.6B |
| Free Cash FlowCash after capex | -$26M | $7.2B | $23.6B | $4.4B |
| Gross MarginGross profit ÷ Revenue | +22.7% | +55.5% | +21.7% | +19.6% |
| Operating MarginEBIT ÷ Revenue | +10.7% | +27.4% | +10.5% | +14.0% |
| Net MarginNet income ÷ Revenue | -17.9% | +12.2% | +8.9% | +9.4% |
| FCF MarginFCF ÷ Revenue | -4.6% | +13.9% | +7.3% | +8.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -20.8% | +25.1% | -1.3% | -12.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -3.6% | +30.1% | -11.0% | +78.7% |
Valuation Metrics
GFR leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 12.1x trailing earnings, GFR trades at a 45% valuation discount to XOM's 21.9x P/E. On an enterprise value basis, SU's 5.1x EV/EBITDA is more attractive than XOM's 10.9x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $410M | $75.7B | $620.8B | $53.6B |
| Enterprise ValueMkt cap + debt − cash | $383M | $86.5B | $653.7B | $64.1B |
| Trailing P/EPrice ÷ TTM EPS | 12.07x | 17.93x | 21.86x | 18.06x |
| Forward P/EPrice ÷ next-FY EPS est. | 16.65x | 7.73x | 14.79x | 7.47x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 8.99x | 5.13x | 10.91x | 8.91x |
| Price / SalesMarket cap ÷ Revenue | 0.97x | 2.11x | 1.92x | 1.47x |
| Price / BookPrice ÷ Book value/share | 0.48x | 2.35x | 2.37x | 2.24x |
| Price / FCFMarket cap ÷ FCF | 23.05x | 14.92x | 26.29x | 21.48x |
Profitability & Efficiency
Evenly matched — GFR and SU and CVE each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
CVE delivers a 15.2% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $-10 for GFR. GFR carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to CVE's 0.54x. On the Piotroski fundamental quality scale (0–9), SU scores 6/9 vs XOM's 3/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -10.0% | +14.0% | +10.7% | +15.2% |
| ROA (TTM)Return on assets | -7.8% | +7.0% | +6.4% | +7.8% |
| ROICReturn on invested capital | +3.9% | +20.1% | +8.6% | +7.9% |
| ROCEReturn on capital employed | +5.5% | +19.5% | +8.9% | +8.2% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 3 | 6 |
| Debt / EquityFinancial leverage | 0.01x | 0.41x | 0.16x | 0.54x |
| Net DebtTotal debt minus cash | -$36M | $14.7B | $32.9B | $14.3B |
| Cash & Equiv.Liquid assets | $42M | $3.6B | $10.7B | $2.7B |
| Total DebtShort + long-term debt | $6M | $18.4B | $43.5B | $17.0B |
| Interest CoverageEBIT ÷ Interest expense | 0.48x | 11.68x | 69.44x | 11.80x |
Total Returns (Dividends Reinvested)
Evenly matched — SU and CVE each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CVE five years ago would be worth $38,679 today (with dividends reinvested), compared to $5,246 for GFR. Over the past 12 months, CVE leads with a +147.0% total return vs GFR's +43.7%. The 3-year compound annual growth rate (CAGR) favors SU at 31.8% vs GFR's -19.4% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +17.7% | +40.8% | +20.3% | +63.2% |
| 1-Year ReturnPast 12 months | +43.7% | +92.7% | +43.9% | +147.0% |
| 3-Year ReturnCumulative with dividends | -47.5% | +128.8% | +44.9% | +85.3% |
| 5-Year ReturnCumulative with dividends | -47.5% | +201.0% | +164.6% | +286.8% |
| 10-Year ReturnCumulative with dividends | -47.5% | +197.4% | +105.0% | +118.2% |
| CAGR (3Y)Annualised 3-year return | -19.4% | +31.8% | +13.2% | +22.8% |
Risk & Volatility
Evenly matched — XOM and CVE each lead in 1 of 2 comparable metrics.
Risk & Volatility
XOM is the less volatile stock with a -0.15 beta — it tends to amplify market swings less than CVE's 0.22 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CVE currently trades 92.3% from its 52-week high vs GFR's 80.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.05x | -0.03x | -0.15x | 0.22x |
| 52-Week HighHighest price in past year | $7.06 | $70.29 | $176.41 | $30.84 |
| 52-Week LowLowest price in past year | $3.81 | $33.50 | $101.19 | $11.60 |
| % of 52W HighCurrent price vs 52-week peak | +80.2% | +90.7% | +83.0% | +92.3% |
| RSI (14)Momentum oscillator 0–100 | 42.6 | 48.7 | 42.4 | 63.0 |
| Avg Volume (50D)Average daily shares traded | 239K | 4.6M | 18.9M | 13.1M |
Analyst Outlook
XOM leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: GFR as "Buy", SU as "Buy", XOM as "Hold", CVE as "Hold". Consensus price targets imply 9.5% upside for XOM (target: $160) vs -2.8% for CVE (target: $28). For income investors, XOM offers the higher dividend yield at 2.73% vs CVE's 2.01%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | — | $62.00 | $160.43 | $27.67 |
| # AnalystsCovering analysts | 1 | 31 | 55 | 27 |
| Dividend YieldAnnual dividend ÷ price | — | +2.6% | +2.7% | +2.0% |
| Dividend StreakConsecutive years of raises | 1 | 4 | 26 | 0 |
| Dividend / ShareAnnual DPS | — | $2.30 | $4.00 | $0.78 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.0% | +3.3% | +3.4% |
SU leads in 1 of 6 categories (Income & Cash Flow). GFR leads in 1 (Valuation Metrics). 3 tied.
GFR vs SU vs XOM vs CVE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is GFR or SU or XOM or CVE a better buy right now?
For growth investors, Suncor Energy Inc.
(SU) is the stronger pick with -3. 5% revenue growth year-over-year, versus -27. 4% for Greenfire Resources Ltd. (GFR). Greenfire Resources Ltd. (GFR) offers the better valuation at 12. 1x trailing P/E (16. 6x forward), making it the more compelling value choice. Analysts rate Greenfire Resources Ltd. (GFR) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GFR or SU or XOM or CVE?
On trailing P/E, Greenfire Resources Ltd.
(GFR) is the cheapest at 12. 1x versus Exxon Mobil Corporation at 21. 9x. On forward P/E, Cenovus Energy Inc. is actually cheaper at 7. 5x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — GFR or SU or XOM or CVE?
Over the past 5 years, Cenovus Energy Inc.
(CVE) delivered a total return of +286. 8%, compared to -47. 5% for Greenfire Resources Ltd. (GFR). Over 10 years, the gap is even starker: SU returned +197. 4% versus GFR's -47. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GFR or SU or XOM or CVE?
By beta (market sensitivity over 5 years), Exxon Mobil Corporation (XOM) is the lower-risk stock at -0.
15β versus Cenovus Energy Inc. 's 0. 22β — meaning CVE is approximately -254% more volatile than XOM relative to the S&P 500. On balance sheet safety, Greenfire Resources Ltd. (GFR) carries a lower debt/equity ratio of 1% versus 54% for Cenovus Energy Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — GFR or SU or XOM or CVE?
By revenue growth (latest reported year), Suncor Energy Inc.
(SU) is pulling ahead at -3. 5% versus -27. 4% for Greenfire Resources Ltd. (GFR). On earnings-per-share growth, the picture is similar: Cenovus Energy Inc. grew EPS 28. 7% year-over-year, compared to -62. 4% for Greenfire Resources Ltd.. Over a 3-year CAGR, SU leads at -5. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GFR or SU or XOM or CVE?
Suncor Energy Inc.
(SU) is the more profitable company, earning 12. 1% net margin versus 7. 9% for Cenovus Energy Inc. — meaning it keeps 12. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SU leads at 31. 7% versus 8. 8% for CVE. At the gross margin level — before operating expenses — SU leads at 59. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GFR or SU or XOM or CVE more undervalued right now?
On forward earnings alone, Cenovus Energy Inc.
(CVE) trades at 7. 5x forward P/E versus 16. 6x for Greenfire Resources Ltd. — 9. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for XOM: 9. 5% to $160. 43.
08Which pays a better dividend — GFR or SU or XOM or CVE?
In this comparison, XOM (2.
7% yield), SU (2. 6% yield), CVE (2. 0% yield) pay a dividend. GFR does not pay a meaningful dividend and should not be held primarily for income.
09Is GFR or SU or XOM or CVE better for a retirement portfolio?
For long-horizon retirement investors, Exxon Mobil Corporation (XOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
15), 2. 7% yield, +105. 0% 10Y return). Both have compounded well over 10 years (XOM: +105. 0%, GFR: -47. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GFR and SU and XOM and CVE?
Both stocks operate in the Energy sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: GFR is a small-cap deep-value stock; SU is a mid-cap deep-value stock; XOM is a large-cap quality compounder stock; CVE is a mid-cap quality compounder stock. SU, XOM, CVE pay a dividend while GFR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.